Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Insulin Articles

What are your thoughts on insulin pumps?
Community’s Positive Effect on Diabetes Management
At the Crossroads, I Choose Insulin
Reduced Insulin May Prevent Exercise-Related Hypoglycemia
An Interview With My Husband, Rick
Living With Type 1 Diabetes
Smaller, Lighter OmniPod Earns FDA Approval
We’re Not Bad, We’re Human
The Penalty of Not Being Able to Afford Care Is Too Expensive
Can you please explain the dawn phenomenon, and how best to manage it?
Diabetes Health Reference Charts
Mail Order Reference Guide (PDF)
Infusion Sets Reference Guide (PDF)
Mail Order Reference Guide (PDF)
Insulin Pumps Reference Guide (PDF)
Insulin Pen Needles Reference Guide (PDF)
Lancing Devices Reference Guide (PDF)
Lancing Devices Reference Guide (PDF)
Syringes Reference Guide (PDF)
Insulin Reference Guide (PDF)
See All Charts…
Insulin Archives
Browse the Insulin Archives
Subscribe to the Medications RSS Feed
Print | Email | Share | Comments (0)

EU OKs Insulin Delivery Device for Type 2s


Dec 2, 2012

CeQur SA, a Swiss company that develops insulin delivery devices, has received approval to market its PaQ® insulin delivery device in Europe.

The PaQ is a wearable device that delivers three days' worth of basal, as well as on-demand bolus, insulin for people with type 2 diabetes. The device combines a disposable insulin-infuser reservoir with a reusable insulin monitor to function.

CeQur spokesmen estimate that more than 30 million in the 27-nation European Union take multiple daily injections of insulin to manage their diabetes, including a substantial number of type 2s. Because tight control of blood glucose levels is essential to avoiding long-term complications from diabetes, adhering closely to a dosing schedule is important.

However, the company estimates that half of all patients taking insulin intentionally skip doses if they find giving themselves an injection to be embarrassing, inconvenient, painful, or disruptive. CeQur believes that continuous insulin-infusion technology, discretely attached under clothing, will do much to improve drug adherence.

Established in 2008 in Switzerland, CeQur also has a production facility in Marlborough, Massachusetts. Even though it has a U.S. location, the company has not said when it might ask for FDA approval to sell the PaQ in the American market.

CeQur's website is located at www.cequrcorp.com.

Categories: Basal, Bolus, Diabetes, Diabetes Health, Diabetes Health Magazine, Diabetic, Injections, Insulin, Research

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Dec 2, 2012

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.